/channels-contribute/taxonomy/term/21/all en /channels-contribute/channels/event/2015-quebec-france-ms-als-meeting-254545 <p>The 3rd Biogen Idec-sponsored meeting of MS and ALS researchers in Quebec and Montpellier France will be held at the Neuro on October 15 and 16, 2015.   This meeting is co-organized by the Neuro and William Camu, Montpelier (France).</p> Thu, 13 Aug 2015 20:24:25 +0000 deborah.rashcovsky@mcgill.ca 1275 at /channels-contribute /channels-contribute/channels/news/june-als-awareness-month-236886 <p align="center" style="text-align:left"><b><span style="text-decoration:underline">What is ALS?</span></b></p> Mon, 02 Jun 2014 15:47:46 +0000 anita.kar@mcgill.ca 1051 at /channels-contribute /channels-contribute/channels/news/everything-moderation-excessive-nerve-cell-pruning-leads-disease-230995 <p><i>Mechanism meant to maintain efficiency of brain network involved in neurodegenerative disease</i></p> Tue, 08 Oct 2013 13:59:39 +0000 anita.kar@mcgill.ca 813 at /channels-contribute /channels-contribute/channels/news/june-als-awareness-month-227292 <p><strong>What is ALS?</strong><br />Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig’s disease, is a neurodegenerative disease in which progressive muscle weakness leads to paralysis. ALS is a result of the death of motor neurons (nerve cells) in the brain and spinal cord that control voluntary muscle movement. Most people survive less than five years following diagnosis, but a small percentage of patients live for ten years or even longer. So far, there is no cure. About 3,000 Canadian adults have ALS and less than 1 in 10 patients have a family history of the disease. </p> Thu, 13 Jun 2013 14:34:34 +0000 anita.kar@mcgill.ca 746 at /channels-contribute